Synthesis and bioevaluation of a series of α-pyrone derivatives as potent activators of Nrf2/ARE pathway (part I)

  • Eur J Med Chem. 2013 Aug:66:364-71. doi: 10.1016/j.ejmech.2013.06.007.
Mei-yang Xi  1 ,  Zhong-ying Sun ,  Hao-peng Sun ,  Jian-min Jia ,  Zheng-yu Jiang ,  Lei Tao ,  Ming Ye ,  Xi Yang ,  Ya-jing Wang ,  Xin Xue ,  Jing-jie Huang ,  Yuan Gao ,  Xiao-ke Guo ,  Sheng-lie Zhang ,  Ying-rui Yang ,  Qing-long Guo ,  Rong Hu ,  Qi-dong You
Affiliations
  • 1. Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.
Abstract

When exposed to electrophiles, human Colorectal Cancer cells (HCT116) counteract oxidative stress through activating NF-E2-related factor 2 (Nrf2)/antioxidant response element (ARE) pathway. To identify new activators, luciferase reporter gene assay was used to screen in-house database of our laboratory, leading to a novel α-pyrone compound 1 as a hit. 2 with 2-fluoro phenyl group exhibited the strongest ARE inductive activity in the first round structure-activity relationship (SAR) study. Biological studies showed the compound induced nuclear translocation of Nrf2 preceded by phosphorylation of ERK1/2. The data encouraged us to use 2 as lead and 20 derivatives were synthesized to discuss a more detailed SAR, leading to a more potent compound 9, which can be the starting compound for further modification.

Keywords
ARE; Chemopreventive agents; Keap1; Nrf2; α-Pyrone derivative.